Markets › India › NSE › PGHL

Procter & Gamble Health Ltd

NSE:PGHLHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹5,135.50−1.24%At closeAt close · Mon 19 Oct · ≈ AED 198.42 · Market cap $909.12M · Next earnings Wed 2 Dec

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	2.3	2.5	3.1	2.0	3.1	4.5	+43.9%
Depreciation & amortization	0.3	0.3	0.3	0.3	0.2	0.2	+6.0%
Stock-based compensation	0.0	0.1	0.0	0.0	0.0	0.0	—
Change in working capital	0.5	(0.5)	(0.3)	(0.1)	(0.7)	(0.2)	+68.3%
Operating cash flow	2.5	1.7	2.4	2.3	1.8	3.4	+92.1%
Capital expenditure	(0.5)	(0.4)	(0.4)	(0.2)	(0.1)	(0.2)	−81.2%
Acquisitions	0.0	0.0	0.0	0.0	0.1	0.0	−100.0%
Investing cash flow	(0.3)	(0.3)	(0.2)	(0.1)	0.0	0.0	−48.4%
Dividends paid	(0.7)	(2.8)	(0.9)	(4.1)	(2.3)	(3.4)	−46.4%
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.0	0.0	0.0	0.0	0.0	0.0	—
Financing cash flow	(3.9)	(2.9)	(1.0)	(4.2)	(2.3)	(3.4)	−46.5%
Free cash flow	1.9	1.3	1.9	2.1	1.7	3.2	+92.7%
Net change in cash	(1.7)	(1.4)	1.2	(2.0)	(2.5)	(0.0)	+98.1%